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Nontuberculous mycobacteria are increasingly associ-
ated with cutaneous infections after cosmetic procedures. 
Fractionated CO2 resurfacing, a widely used technique for 
photorejuvenation, has been associated with a more favor-
able side effect profile than alternative procedures. We de-
scribe 2 cases of nontuberculous mycobacterial infection af-
ter treatment with a fractionated CO2 laser at a private clinic. 
Densely distributed erythematous papules and pustules de-
veloped within the treated area within 2 weeks of the laser 
procedure. Diagnosis was confirmed by histologic analysis 
and culture. Both infections responded to a 4-month course 
of a multidrug regimen. An environmental investigation of 
the clinic was performed, but no source of infection was 
found. The case isolates differed from each other and from 
isolates obtained from the clinic, suggesting that the infec-
tion was acquired by postprocedure exposure. Papules and 
pustules after fractionated CO2 resurfacing should raise the 
suspicion of nontuberculous mycobacterial infection.
Nontuberculous mycobacteria (NTM) are increasingly associated with cutaneous and soft tissue infections 
after cosmetic and spa procedures, such as liposuction, 
mammoplasty, blepharoplasty, mesotherapy, and whirlpool 
footbaths during pedicures (1–5). These infections are of-
ten difficult to diagnose, resulting in major treatment delays 
(4,6). Fractionated CO2 laser resurfacing is a widely used 
cosmetic procedure that minimizes the appearance of rhyt-
ides (skin wrinkles) and acne scars, and compared with older 
laser procedures, fractionated CO2 resurfacing is associated 
with less downtime and a lower rate of infectious and non-
infectious complications (7–9). Although fractionated CO2 
laser therapy is associated with decreased rates of postpro-
cedure infection, infections such as herpes simplex virus, 
bacterial, and candidal infections have been reported (8–10). 
Palm et al. recently reported the first case of NTM infec-
tion caused by Mycobacterium chelonae after treatment with 
a fractionated CO2 laser for facial resurfacing (11). Given 
the length of time from the procedure to the diagnosis (≈2 
months), a source of NTM infection was not sought.
We report 2 additional cases of NTM infection after 
treatment with fractionated CO2 resurfacing at the same 
private clinic and an extensive environmental investigation 
to identify a source of infection. This study received for-
mal exemptions from review by the Institutional Review 
Boards of the University of North Carolina and Duke Uni-
versity Medical Center.
Case-Patient 1
A 53-year-old woman had multiple erythematous pap-
ules and pustules densely distributed over her face, neck, 
and chest (Figure 1, panel A) 2 weeks after receiving frac-
tionated CO2 laser resurfacing (Solta Medical Inc., Hay-
ward, CA, USA). Before laser resurfacing, the patient began 
a prophylactic 7-day course of valacyclovir because of a 
history of recurrent herpes labialis. Immediately before the 
procedure, the patient’s skin was cleansed with 70% isopro-
panol. Topical lidocaine/tetracaine ointment was applied to 
the skin for topical anesthesia, followed by intraoral nerve 
block and tumescent anesthesia for the face only. The neck 
and chest were treated at 40 mJ (treatment level 7 mJ) and 
25% coverage, the forehead at 60 mJ (treatment level 9 mJ) 
and 35% coverage, and the nose and cheeks at 70 mJ (treat-
ment level 9 mJ) and 35% coverage (total 10.46 kJ). Imme-
diately after the procedure, the patient’s skin was cleansed 
with sterile saline, and emollient was applied. Postprocedure 
home wound care consisted of vinegar solution (vinegar di-
luted with bottled water) applications once a day and avoid-
ance of showering, scrubbing, and cosmetics for 72 h.
Ten days post–laser treatment, erythematous papules 
and pustules developed over the face, neck, and chest of 
the patient. Outpatient treatment was initiated with oral 
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fluconazole, doxycycline, and valacyclovir for presumed 
fungal, staphylococcal, or disseminated herpes simplex 
virus infection. Because of extensive pruritus, the patient 
was given locoid lipocin (0.1% hydrocortisone butyrate) 
and a tapered dose of prednisone for possible allergic con-
tact dermatitis. She reported adherence to instructions to 
avoid showering and washing her face with tap water for 
72 h after the procedure. However, she was exposed to dust 
from sanding she did at home during the week after the pro-
cedure. She did not show improvement over the next 2 days 
and, after a low-grade fever developed, was hospitalized 
and received intravenous acyclovir therapy for presumed 
disseminated herpes simplex virus infection.
When the patient was hospitalized, lesions were nearly 
confluent over her neck and chest and scattered over her 
face but limited to areas treated with the CO2 laser. PCR 
results for herpes simplex virus, varicella zoster virus, and 
fungal cultures were negative. Gram staining showed poly-
morphonuclear leukocytes and gram-variable rods. Two 
skin biopsy specimens demonstrated multiple, tiny foci of 
suppurative granulomatous dermatitis with elastophago-
cytosis (Figure 2, panel A) and numerous long acid-fast 
rods that were gram positive (Figure 2, panel B).
The patient was given empiric treatment for nontuber-
culous mycobacterial infection with intravenous tigecycline 
combined with oral moxifloxacin and azithromycin. Two 
weeks later, tissue culture of her lesions grew M. absces-
sus. Drug susceptibility testing showed resistance to moxi-
floxacin, amoxicillin/clavulanate, tobramycin, trimethoprim/
sulfamethoxazole, ciprofloxacin, doripenem, linezolid, and 
doxycycline, and susceptibility to azithromycin, amikacin, 
kanamycin, imipenem, cefoxitin, and tigecycline.
One month after initiation of the multidrug regimen, re-
peat culture of a persistent pustule on her face again grew M. 
abscessus. Treatment with tigecycline and moxifloxacin was 
stopped after 2 months and treatment with azithromycin was 
stopped after 5 months because the patient showed clinical 
improvement. Scarring and dyspigmentation were observed. 
Thus, for cosmesis, she subsequently underwent a series of 
procedures with a pulsed dye laser (Figure 1, panel B).
Case-Patient 2
A 52-year-old woman underwent fractionated CO2 
laser resurfacing of the neck at the same private clinic as 
case-patient 1 (66 days after case-patient 1 was treated). Af-
ter case-patient 1 was treated, major changes were made in 
the treatment protocol to make the procedure sterile. Treat-
ment was performed at 30 mJ (treatment level 7) with 25% 
coverage (total 2.96 kJ) but otherwise as for case-patient 
1. Nine days after the procedure, painful pustular lesions 
developed within the treated area but primarily on the right 
neck (Figure 3, panel A). The patient reported adherence 
with instructions to avoid washing with tap water for 72 
hours after the procedure and denied any other exposures. 
Treatment was initiated with valacyclovir, cephalexin, and 
topical antimicrobial drugs.
After this patient did not show improvement, a biopsy 
specimen from a lesion showed suppurative and granuloma-
tous dermatitis, which suggested NTM infection. Empiric 
treatment for NTM infection was initiated with azithromy-
cin and moxifloxacin; some improvement in the lesions was 
subsequently observed. The organism was identified as M. 
chelonae. Drug susceptibility testing showed resistance to 
cefoxitin and trimethoprim/sulfamethoxazole; intermediate 
susceptibility to ciprofloxacin; and susceptibility to amika-
cin, clarithromycin, linezolid, and tobramycin. Treatment 
was continued with azithromycin and moxifloxacin for 4 
months and clinical improvement was observed (Figure 3, 
panel B).
Epidemiologic Investigation
After case 1 was detected, an epidemiologic investiga-
tion was requested by the physician (dermatologist) who 
had performed the laser resurfacing to investigate possible 
sources of the infection within the clinic. The investigation 
was initiated 27 days after the procedure was performed. 
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Figure 1. A) Neck and chest 
of a 53-year-old woman 
(case-patient 1) 14 days 
after fractionated CO2 laser 
resurfacing. B) Neck of 
the patient after 5 months 
of multidrug therapy and 
pulsed dye laser treatment. 
Mycobacterial Infection after Laser Resurfacing
We interviewed the dermatologist and reviewed all steps of 
the procedure. Several items were obtained and cultured for 
nontuberculous mycobacteria: a multiuse jar of lidocaine/
tetracaine ointment, a multiuse jar of emollient, a multiuse 
vial of 1% lidocaine used for nerve blocking, a nonsterile 
package of gauze used to apply ointments to patients’ skin, 
and a multiuse vial of sodium bicarbonate. Small amounts 
of samples were swabbed onto 7H10 Middlebrook me-
dium supplemented with an additional 5 µg/mL of mala-
chite green by using a sterile swab. A gauze square was 
immersed in ≈250 mL sterile water and agitated vigorously 
for ≈1 min. The water was then filtered through a 0.4-m 
sterile filter, and the filter was plated directly onto the 7H10 
Middlebrook medium. Approximately 0.1 mL of each of 
the other samples was placed directly onto a 7H10 Middle-
brook medium plate and spread over the plate by using a 
sterile loop. Plates were incubated at 30°C, and no growth 
was observed on any plates after 3 months of incubation.
Although no obvious source of infection was identi-
fied, several changes to the routine fractionated CO2 re-
surfacing procedure were made after case 1 was detected. 
These changes included use of sterile gloves; sterile gauze; 
sterile tongue depressors for application of topical lido-
caine/tetracaine ointment; conversion to single-use vials of 
lidocaine, epinephrine, and sterile saline used for tumes-
cent anesthesia; and single-use postprocedure emollient. 
Chloroxylenol (3%) was also added in addition to 70% iso-
propanol for preprocedure cleansing. Postprocedure wound 
care was not changed.
After case 2 was detected, a second site visit was ar-
ranged 46 days after the procedure was performed. The 
dermatologist was interviewed again, and a complete sham 
procedure was performed while the investigators observed. 
Samples were collected from the 3% chloroxylenol, hand 
scrub, multiuse sodium bicarbonate vial, and single-use 
lidocaine/tetracaine ointment vial. The suction canister, 
connection tubing, and smoke filter were removed from 
the machine and cultured. Copious amounts of skin debris 
were identified in the long and short tubes of the connection 
tubing, along with an »2 to 3–cm layer of skin debris on top 
of the smoke filter. Environmental swabs of the countertops 
and walls in the procedure room were also collected. Water 
specimens (≈250 mL) were collected from the taps in the 
staff and patient bathrooms in the clinic (there was no water 
source in the procedure room or any other nearby proce-
dure rooms) and from a fountain in the hallway. Patients 
were routinely instructed to wash the area with soap and 
water before coming to the office (i.e., they did not wash in 
the patient sink in the office).   
The ointments were plated directly onto Lowenstein-
Jensen (LJ) and modified 7H10 medium. The environmen-
tal swab was plated directly onto LJ medium only. Two 1 × 
3–cm pieces of the paper filter from the filter canister were 
plated directly onto LJ medium. In addition, the multiuse 
lidocaine/tetracaine ointment from the first site visit was 
plated directly onto LJ medium by using a sterile swab. Ap-
proximately 100 mL of sterile water were passed through 
the canister/short tube and the long tube from the apparatus 
and collected in sterile bottles. The resultant suspensions 
were brown and contained large quantities of skin debris. 
Approximately 40 mL of each water sample and 10 mL of 
the sodium bicarbonate were passed through 0.4-m filters; 
each specimen was processed in duplicate. One filter from 
each specimen was then plated directly onto LJ medium, 
and the other filter was plated onto malachite green–sup-
plemented 7H10 medium. Medium plates were incubated 
at 30°C. After 1 week, mycobacterial colonies were identi-
fied on the medium containing the filtrate from the con-
nector tubing and several of the tap water specimens (staff 
bathroom and patient bathroom).
Species identification of all isolates was performed at 
the Microbiology Laboratory of the University of North 
Carolina by using 16S rRNA and heat shock protein 65 
gene sequencing. Results of sequence analysis showed that 
the 2 patient isolates did not match. They were identical 
by sequencing of part of the 16S rRNA gene but differed 
by heat shock protein 65 sequencing; the organism isolated 
from case-patient 1 was M. abscessus and that from case-
patient 2 was M. chelonae. Analysis of clinic water isolates 
showed several different mycobacterial organisms. Four 
colony morphologies were isolated from the tap water in 
the patient bathroom, 2 of which were identified as M. mu-
cogenicum, 1 as M. obuense/aurum, and 1 as M. chelonae. 
Three colonies isolated from the tap in the staff bathroom 
were identified as M. mucogenicum. The isolate from the 
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Figure 2. Skin biopsy specimens of a 53-year-old woman (case-
patient 1) after fractionated CO2 laser resurfacing. A) Hematoxylin 
and eosin–stained and B) Ziehl-Neelsen acid-fast–stained sections 
show a tiny superficial microabscess surrounded by sparse 
granulomatous inflammation. Several groups of acid-fast organisms 
can be seen at the lower left of panel B. Original magnifications 
×400 in (A) and ×600 in (B). 
SYNOPSIS
large tubing leading to the smoke filter was M. smegmatis, 
which was not a match with either patient isolate.
Pulsed-field gel electrophoresis was performed at the 
University of Texas at Tyler to compare the M. chelonae 
isolate from the case-patient 2 with the isolate from the pa-
tient bathroom in the dermatology clinic. The 2 isolates did 
not match.
Environmental investigation of the homes of the 2 pa-
tients was not conducted because case-patient 1 refused and 
sampling of the home of case-patient 2 was not attempted. 
The bottles of vinegar used for postprocedure cleansing 
were not available for either patient. Neither patient  had 
undergone fractionated CO2 laser  resurfacing before the 
procedures described.
Conclusions
NTM are environmental organisms that are increasingly 
associated with systemic and cutaneous disease in humans. 
NTM-induced cutaneous disease typically occurs after in-
jections, such as tattoos, botulinum toxin, and mesotherapy, 
or after minor surgical procedures in which breaks in the 
skin barrier occur (1,3,5,12–15). These organisms also have 
been associated with whirlpool footbaths before pedicures 
(2,4,16). In these cases, shaving before a whirlpool footbath 
was associated with increased rates of infection, presumably 
caused by microbreaks in the skin, which enable easy inocu-
lation (2,16,17). NTM are ubiquitous in soil and water and 
have been detected in municipal water sources throughout 
the United States (16,18,19). They are also found in bio-
films and, in the whirlpool footbath associated cases, seem 
to thrive in nutrient-rich water contaminated by skin debris, 
which accumulates on bath filters (2,4,16,17).
Eradication can be difficult because these organisms are 
resistant to most disinfectants (4,20,21). Cutaneous infection 
with NTM is most often caused by M. marinum and rapidly 
growing mycobacteria that belong to 1 of 3 species groups: 
M. abscessus, M. chelonae, and M. fortuitum (22–24). 
Diagnosis is difficult and often requires histologic evaluation 
and tissue samples for culture. Delays in diagnosis are com-
mon and can lead to delays in treatment (6). Species identi-
fication can be difficult and requires sequencing of multiple 
genes because of homology between Mycobacterium spp. 
family members (25–27). More than 120 NTM species have 
been identified, including ≈30 isolates in the past decade 
whose names might be unfamiliar to many clinicians (28). 
These organisms are also resistant to many antimicrobial 
drugs, a factor that complicates treatment.
In the past 5 years, fractionated CO2 laser resurfacing 
has become the preferred procedure for rhytides, photo-
damage, and acne scars (9). This procedure combines the 
efficacy of ablative laser resurfacing with a more favorable 
side effect profile than traditional ablative therapy. Stud-
ies have shown a high degree of safety and efficacy and 
lower rates of hypopigmentation, scarring, and infectious 
complications (7–10,29). This technology is based on the 
principle of creating narrow columns of tissue damage 
known as microthermal treatment zones, which are evenly 
distributed over the treated area. Localized epidermal ne-
crosis and collagen denaturation occur in each column but 
the stratum corneum remains intact. Decreased disruption 
of the epidermal barrier and areas of viable tissue around 
each microthermal treatment zone enable more rapid heal-
ing and reduce the risk of infection.
Although infections with fractionated CO2 laser ther-
apy are less common than with traditional ablative laser, 
they do occur (10). Infection with herpes simplex virus was 
reported in 1.7% of all cases and in 4.6% of cases in which 
the patient had a history of oral herpes but no antivirus pro-
phylaxis was given (8). Bacterial complications, including 
Staphylococcus spp. and Pseudomonas spp. infections, and 
Candida spp. infections have also been reported, although 
at low rates (10).
Palm et al. reported the first case of NTM infection af-
ter fractionated laser resurfacing (11). The causative agent 
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Figure 3. A) Right lateral 
neck of a 52-year-old 
woman (case-patient 2) 9 
days after fractionated CO2 
laser resurfacing. B) Neck 
of the patient after 4 months 
of multidrug therapy. 
Mycobacterial Infection after Laser Resurfacing
was identified as M. chelonae 3 months after the onset of 
acneiform eruptions. The patient received multidrug treat-
ment and showed some clinical improvement. She eventu-
ally underwent therapy with a pulsed dye laser and showed 
a decrease in erythema and scarring. A possible source of 
NTM infection was not sought in this case.
We report 2 additional cases of NTM infection with M. 
abscessus and M. chelonae after fractionated CO2 laser re-
surfacing. Both patients showed development of erythema-
tous papules and pustules »10–14 days after the procedure, 
but the extent of skin involvement varied between the 2 pa-
tients. For both patients, a diagnosis was made within 1–2 
weeks by histologic examination and tissue culture. Early 
treatment with multidrug therapy specific for the most like-
ly mycobacterial pathogens was initiated while susceptibil-
ity testing was performed. In both patients, treatment was 
continued for >4 months.
Results of a thorough epidemiologic investigation 
showed no evidence that transmission of the NTM infec-
tions occurred during the fractionated resurfacing proce-
dure. The 2 patient isolates belonged to 2 different species, 
and neither matched the isolate obtained from the fraction-
ated laser apparatus. Furthermore, none of the isolates from 
environmental water at the clinic matched either patient 
isolate. Although the absence of evidence does not defini-
tively rule out common source transmission during the pro-
cedure, it does make it more likely that infection occurred 
elsewhere after the procedure.
The source of these infections remains unclear. It is 
possible that the causative NTM isolates were transiently 
present in the environment but were not detected because 
of lag times between procedures and environmental in-
vestigations. Furthermore, limitations of environmental 
sampling and culture for mycobacteria did not enable us 
to rule out a common source of infection at the time of the 
procedure. Detailed environmental sampling of the home 
was not permitted by the first patient and was not sought 
for the second patient. Several alternative environmental 
sources for infection are possible (aerosols from sinks, toi-
lets, water fountains, and sanding dust for case-patient 1). 
Although there was no evidence to support exposure during 
the fractionated laser procedure, an NTM species was iso-
lated from the tubing of the machine. Therefore, the tubing 
leading to the smoke filter is a potential reservoir for NTM 
because it is changed infrequently and can contain skin de-
bris within the corrugated tubing.
Patients should be explicitly advised of the risk for NTM 
infection after fractionated laser resurfacing, and physicians 
should be highly suspicious of such infections during the 
postprocedure period. Although incubation periods reported 
for postprocedure NTM have been reported as 9–10 days, 
other cutaneous NTM infections may be found <3 months 
after the presumed exposure (16). Thus, late manifestations 
might be possible. Biopsy specimens for histologic evalu-
ation and tissue culture are critical for making an accurate 
diagnosis. Suppurative neutrophilic and granulomatous der-
matitis should raise suspicion for NTM infection, even if re-
sults of staining for acid-fast bacilli are negative. As shown 
by these cases and the case described by Palm et al. (11), 
identification of gram-positive rods during routine histologic 
examination might suggest NTM infection because these or-
ganisms can be weakly gram positive.
Empiric therapy specific for NTM should be consid-
ered while awaiting biopsy and culture results for patients 
with suspicious lesions. However, prophylactic therapy be-
fore or after the procedure with active agents against NTM 
is not recommended. The efficacy of such treatment in pre-
venting infection remains unknown, and the risk for anti-
microbial drug–associated side effects likely outweighs any 
theoretical benefit. Although there is no standard treatment 
for cutaneous NTM infections, multidrug therapy is usually 
necessary to minimize the development of drug resistance. 
Antimicrobial drug susceptibility testing should be conduct-
ed to tailor therapy, and treatment should be continued for 
4–6 months.
When these infections occur, systematic observation of 
the procedure should be performed. Specifically, attention 
should be paid to any liquids or ointments that may contact 
the skin of a patient during or just after the procedure (par-
ticularly multiuse vials or containers) and the proximity of 
the procedure room to potentially aerosol-generating water 
sources. Environmental sampling with mycobacterial cul-
ture of such liquids seems to be a reasonable first step in 
identifying a source (although it did not identify a source 
in this study).
Furthermore, strict postprocedure wound care is criti-
cal to minimize risk for NTM infection. It is prudent to 
advise patients to avoid any municipal water sources for the 
first 72 h after the procedure (although this time interval is 
arbitrary). Bottled water, which may not be sterile, could 
harbor small amounts of NTM. Use of sterile water or ster-
ile saline for postprocedure cleansing is recommended. 
First and foremost, physicians must remain aware of this 
potential complication of fractionated laser resurfacing and 
be highly suspicious even if initial histologic and culture 
results do not identify microbial pathogens.
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